Cargando…
Pharmacogenomics: A focus on antidepressants and atypical antipsychotics
The study of pharmacogenomics is rapidly growing, particularly in the field of mental health. Understanding pharmacogenomic principles can be a challenge for many clinicians. Most mental health genomic data concentrates on variability (response, side effects) with antidepressants and atypical antips...
Autor principal: | Lister, Jonathan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009243/ https://www.ncbi.nlm.nih.gov/pubmed/29955447 http://dx.doi.org/10.9740/mhc.2016.01.048 |
Ejemplares similares
-
Overview of pharmacogenomic testing in clinical practice
por: Gross, Tonya, et al.
Publicado: (2018) -
Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005) -
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020) -
Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics
por: Koromina, Maria, et al.
Publicado: (2020) -
Pharmacogenomics of antidepressant treatment effects
por: Licinio, Julio, et al.
Publicado: (2011)